| __timestamp | HUTCHMED (China) Limited | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 91813000 | 9757000 |
| Thursday, January 1, 2015 | 178203000 | 1253000 |
| Friday, January 1, 2016 | 216080000 | 5421000 |
| Sunday, January 1, 2017 | 241203000 | 154584000 |
| Monday, January 1, 2018 | 214109000 | 301034000 |
| Tuesday, January 1, 2019 | 204890000 | 380833000 |
| Wednesday, January 1, 2020 | 227976000 | 540099000 |
| Friday, January 1, 2021 | 356128000 | 701887000 |
| Saturday, January 1, 2022 | 426409000 | 933013000 |
| Sunday, January 1, 2023 | 837999000 | 1243336000 |
Cracking the code
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success and market position. Over the past decade, Sarepta Therapeutics, Inc. and HUTCHMED (China) Limited have showcased contrasting trajectories in their financial journeys.
From 2014 to 2023, Sarepta Therapeutics experienced a remarkable revenue surge, growing by over 12,600%, from a modest start to a staggering peak in 2023. This growth reflects Sarepta's strategic advancements in gene therapy and muscular dystrophy treatments. Meanwhile, HUTCHMED (China) Limited, while also growing, saw a more moderate increase of approximately 800% during the same period, highlighting its steady expansion in the oncology and immunology sectors.
This comparison not only underscores the diverse strategies within the biotech industry but also emphasizes the potential for significant financial growth driven by innovation and market demand.
Revenue Insights: Eli Lilly and Company and HUTCHMED (China) Limited Performance Compared
Annual Revenue Comparison: BioMarin Pharmaceutical Inc. vs HUTCHMED (China) Limited
Sarepta Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Sarepta Therapeutics, Inc. or PTC Therapeutics, Inc.: Who Leads in Yearly Revenue?
Who Generates More Revenue? Sarepta Therapeutics, Inc. or Arrowhead Pharmaceuticals, Inc.
Sarepta Therapeutics, Inc. or Geron Corporation: Who Leads in Yearly Revenue?
SG&A Efficiency Analysis: Comparing Sarepta Therapeutics, Inc. and HUTCHMED (China) Limited
Who Generates More Revenue? Sarepta Therapeutics, Inc. or Celldex Therapeutics, Inc.
Breaking Down Revenue Trends: Walgreens Boots Alliance, Inc. vs HUTCHMED (China) Limited
Annual Revenue Comparison: Pharming Group N.V. vs HUTCHMED (China) Limited
Vericel Corporation or HUTCHMED (China) Limited: Who Leads in Yearly Revenue?
Who Generates More Revenue? HUTCHMED (China) Limited or Travere Therapeutics, Inc.